WallStSmart
IDXX

IDEXX Laboratories Inc

NASDAQ: IDXX · HEALTHCARE · DIAGNOSTICS & RESEARCH

$553.66
-2.58% today

Updated 2026-04-29

Market cap
$44.08B
P/E ratio
42.36
P/S ratio
10.24x
EPS (TTM)
$13.07
Dividend yield
52W range
$465 – $770
Volume
0.5M

IDEXX Laboratories Inc (IDXX) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$109.83M$135.12M$143.34M$173.72M$178.83M$220.70M$230.28M$246.00M$235.85M$216.36M$334.57M$373.28M$400.08M$459.16M$648.06M$755.55M$542.98M$906.51M$929.00M$1.18B
Capital expenditures$71.36M$66.24M$89.97M$57.84M$39.30M$100.22M$69.05M$78.64M$60.70M$82.92M$64.79M$76.70M$122.94M$155.22M$107.63M$119.55M$148.84M$133.63M$130.92M$124.68M
Depreciation
Stock-based comp$10.84M$8.78M$10.50M$11.62M$13.26M$15.50M$15.95M$16.54M$18.10M$19.88M$19.89M$23.52M$25.16M$39.28M$30.95M$37.76M$49.77M$59.74M$60.30M$60.01M
Free cash flow$38.47M$68.88M$53.37M$115.88M$139.53M$120.48M$161.23M$167.36M$175.15M$133.44M$269.78M$296.57M$277.15M$303.93M$540.44M$636.00M$394.15M$772.88M$798.08M$1.05B
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$36.11M$51.33M$46.56M
Share repurchases
Debt repayment
Net change in cash$50.19M$26.98M$40.09M$55.07M$43.48M$-193.54M$25.91M$32.77M$-63.88M$-32.78M$290.27M$-234.84M$-23.30M